Micronutrients and Major Depression: A Mendelian Randomisation Study
Nutrients · 2024
DOI: 10.3390/nu16213690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Rebecca E Carnegie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UK. Hauptthemen laut MEDLINE: Major Depressive Disorder, Mendelian Randomization Analysis, Micronutrients, Genome-Wide Association Study. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Institute for Health Research, Diabetes UK.
Themen: Depression
Abstract (Originalsprache)
Background
Various vitamins and minerals have been implicated in the aetiology of depression.
Objective
To estimate the effects of micronutrient exposures on major depressive disorder (MDD) and recurrent depression (rMDD) using Mendelian randomisation (MR), a method using genetic data to estimate causal effects given certain assumptions.
Methods
We undertook a comprehensive bidirectional MR study of multiple micronutrient exposures on MDD and rMDD. Summary statistics were obtained from the Psychiatric Genomics Consortium (PGC) genome-wide association studies (GWASs) of MDD (cases = 116,209; controls = 314,566) and rMDD (cases = 17,451; controls = 62,482).
Results
None of the micronutrients with available genetic instruments were strongly associated with MDD or rMDD using traditional MR methods. However, using methods to increase analytical power by accounting for genetically correlated variants (e.g., cIVW) highlighted five micronutrients with possible causal effects. Point estimates for rMDD were the largest magnitude, with three micronutrients suggestive of a protective effect: serum iron (ORcIVW 0.90 per SD increase; 95% CI 0.85–0.95; p = 0.0003); erythrocyte copper (ORcIVW 0.97; 95% CI 0.95–0.99; p = 0.0004); and 25(OH) vitamin D (ORcIVW 0.81; 0.66–0.99; p = 0.04). Apparent adverse effects of increased selenium on the risk of MDD (ORcIVW 1.03; 95% CI 1.02–1.05; p = 0.0003) and rMDD (ORcIVW 1.08; 95% CI 1.00–1.08; p = 0.06), and serum magnesium on rMDD (ORcIVW 1.21; 1.01–1.44; p = 0.04); were less consistent between methods and may be driven by pleiotropy.
Conclusions
Our results suggest weak evidence for a protective effect of iron, copper and 25(OH)D on major depressive outcomes, with mixed evidence for selenium and magnesium. There was no evidence to support a causal effect of any other micronutrients on MDD or rMDD, although genetic instruments were lacking, with insufficient power to detect small but important effects. Future micronutrient supplementation trials should ensure ample statistical power given modest causal effect estimates and consider potential risks of supplementation, as some micronutrient effect estimates suggested potential harm in excess.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2BN, UK.
- Medical Research Centre (MRC), Integrative Epidemiology Unit (IEU), University of Bristol, Bristol BS8 1QU, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 1QU, UK.
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medici…
- NIHR Biomedical Research Centre, a Partnership between University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.
ORCID-Profile: Rebecca E Carnegie, Hannah J Jones, Sarah J Lewis, Jonathan Evans
Förderung
- Medical Research Council
- National Institute for Health Research
- Diabetes UK
- Wellcome Trust
- National Institute for Health Research Senior Investigator
- University of Bristol
- National Institute for Health Research (NIHR) Bristol Biomedical Research Centre
- the Government Department of Business, Energy and Industrial Strategy
Zitieren
APA
Carnegie, R. E., Zheng, J., Borges, M. C., Jones, H. J., Wade, K. H., Sallis, H. M., Lewis, S. J., Evans, D. M., Revez, J. A., The Major Depressive Disorder Working Group Of The Psychiatric Genomics Consortium, Evans, J., & Martin, R. M. (2024). Micronutrients and Major Depression: A Mendelian Randomisation Study. Nutrients. https://doi.org/10.3390/nu16213690
Vancouver
Carnegie RE, Zheng J, Borges MC, Jones HJ, Wade KH, Sallis HM, et al. Micronutrients and Major Depression: A Mendelian Randomisation Study. Nutrients. 2024. doi:10.3390/nu16213690
BibTeX
@article{Carnegie2024,
author = {Carnegie, Rebecca E and Zheng, Jie and Borges, Maria C and Jones, Hannah J and Wade, Kaitlin H and Sallis, Hannah M and Lewis, Sarah J and Evans, David M and Revez, Joana A and The Major Depressive Disorder Working Group Of The Psychiatric Genomics Consortium and Evans, Jonathan and Martin, Richard M},
title = {Micronutrients and Major Depression: A Mendelian Randomisation Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16213690}
}
EUVIMED